GAS6 and acute myeloid leukemia: Further, we examined GAS6-AS1 expression in an AML cohort in our Institute of Hematology of Union Hospital (IHUH), which revealed that GAS6-AS1 was significantly upregulated in AML patients and that 19.7% (15 of 76) patients showed more than 2-fold increase (Fig. 1F).